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Metabolic Bone Disease in Children
Michael P. Whyte, MD*

T

he first two presentations of this session concemed inborn
errors of metabolism that present during infancy or childhood: carbonic anhydrase II deficiency, and hypophosphatasia.
Each is a rare but instructive enzymopathy that impairs one
"end" ofthe bone remodeling process.

Osteopetrosis with Renal Ihbular Acidosis and
Cerebral Calcification: The Carbonic Anhydrase
II Deficiency Syndrome
Sly (1) described how the autosomal recessive syndrome of
osteopetrosis/renal tubular acidosis/cerebral calcification, first
reported in 1972, was found in 1983 to be a new inborn error of
metabolism. Selective absence of the carbonic anhydrase II (CA
II) isoenzyme was discovered in patient erythrocytes, and halfnormal CA 11 levels were demonstrated in the red cells of obligate carriers. Deficiency of this isoenzyme remains to be shown
in bone and kidney tissue. Thirty patients have been reported to
date. Clinical expressivity is variable but generally resembles
"intermediate" forms of osteopetrosis. Radiographs show a developmental form of generalized osteosclerosis with features
typical of osteopetrosis that may improve with aging; cerebral
calcification is widespread on computed tomography. Most patients have both a proximal and distal renal tubular acidosis. Histopathologic study of bone reveals evidence of unresorbed primary spongiosa—a characteristic feature of all human forms of
osteopetrosis. Sly discussed what this new inborn error of metabolism reveals conceming the physiological role of CA II, including a likely function in osteoclast-mediated bone
resorption.

Pediatric Forms of Hypophosphatasia
Hypophosphatasia is an inheritable form of rickets/osteomalacia that is characterized by deficient activity of the tissue
nonspecific (liver/bone/kidney) isoenzyme of alkaline phosphatase (TNSALP); placental and intestinal ALP activity is unaffected (2). Clinical expressivity is extremely variable and
ranges from intrauterine death from profound skeletal undermineralization to onset of recurrent, slowly healing stress fractures in adult life. Premature loss of deciduous teeth is the most
sensitive clinical manifestation in children. Rickets occurs
although serum levels of calcium and phosphate are not subnormal. There is no effective medical treatment for hypophosphatasia, but early prenatal diagnosis of severe forms is
possible. Three phosphocompounds—phosphoethanolamine,
inorganic pyrophosphate (PPi), and pyridoxal-5'-phosphate
(PLP)—accumulate endogenously. The recent discovery that
plasma PLP levels are elevated in all patients with hypo-
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phosphatasia indicates that TNSALP functions as an ectoenzyme to regulate extracellular, but not intracellular, levels of
a variety of phosphocompounds. Identification in 1988 of a
missense mutation in the TNSALP gene in a patient with classic
perinatal (lethal) hypophosphatasia provides unequivocal evidence for a role for TNSALP in skeletal mineralization. Absence of ecto-TNS ALP activity results in extracellular accumulation of PPi, an inhibitor of hydroxyapatite crystal
formation, which could account for the defective skeletal mineralization (2).

Williams Syndrome
Chesney (3) described the Williams syndrome. Affected children characteristically have a variety of phenotypic abnormalities including elfin facies, microcephaly, stellate iris, epicanthal folds, and cardiac defects including supravalvular aortic
stenosis. Mental deficiency and characteristic personality traits
help to make patients relatively easy to identify. Hypercalcemia
occurs in about 15% of subjects and is associated with failure to
thrive, calcification of the media of blood vessels, hypercalciuria, and nephrocalcinosis. The Williams syndrome is generally a sporadic disorder, but familial cases have been reported.
Chesney reviewed what is known about the pathophysiology of
the hypercalcemia, including evidence for enhanced sensitivity
to vitamin D with excessive intestinal absorption of calcium and
evidence for a possible defect in calcitropic hormone regulation,
since clearance of intravenously administered calcium is decreased in the Williams syndrome.

The Molecular Basis of Clinical Heterogeneity in
Osteogenesis Imperfecta
Byers et al (4) discussed the molecular basis for the clinical
heterogeneity of osteogenesis imperfecta (01). It is now clear
that most clinical forms of OI result from mutations that affect
the expression or structure of the genes that form type I collagen. Following a description of type 1 collagen biosynthesis,
Byers et al summarized the specific biochemical and molecular
defects which have thus far been shown to cause the various
clinical (Sillence) types of 01. In addition to the rare instances of
gene deletion or large rearrangements, more commonly a variety of point mutations are now being identified in the different
forms. Previously it was believed that severe type II 01 was in*Division of Metabolism, The Jewish Hospital of St Louis. MO.
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herited as an autosomal recessive trait, but now it appears from
molecular biological studies that this form results more commonly from sporadic mutation or, when siblings are affected,
from genetic mosaicism. Accordingly, the occurrence risk is
considerably less than the 25% for true autosomal recessive disorders. The authors reviewed the relationship between the
clinical phenotype in OI and the nature of the specific molecular
defect. Our rapidly improving comprehension of the molecular
basis for this clinically heterogenous disorder should help to direct potential medical therapies for the various types of 01.

Neonatal Disorders of Mineral Metabolism
Hillman (5) reviewed the neonatal disorders of mineral metabolism, including early and late neonatal hypocalcemia and
mineralization problems in premature and term infants. Controversies regarding the diagnostic criteria for early neonatal hypocalcemia and the need for therapy were discussed. The necessity of using biochemical criteria, based upon serum ionized
calcium rather than total calcium determination, was emphasized. The mineral and hormonal changes of early and late neonatal hypocalcemia were reviewed, and the role of hypomagnesemia in the latter condition was emphasized. Hillman
discussed how, in term infants, disorders of skeletal mineralization are often related to vitamin D deficiency. However, in premature infants fed breast milk, osteopenia/rickets has resulted
from inadequate delivery of mineral to the skeleton. She emphasized the role of both phosphoms and calcium supplementation
for correction of this problem and reviewed areas where further
research is necessary. Hillman's presentation was followed by an
interesting discussion session which emphasized the role of placental function in regulating skeletal mineralization of the fetus.

Vitamin D Resistant Hypophosphatemic Rickets:
Pathogenesis and Medical IVeatment
Glorieux (6) discussed the clinical expression, pathogenesis,
and medical treatment of vitamin D resistant hypophosphatemic
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rickets (VDRR). Controversy continues as to whether this most
common form of inherited rickets in North America results from
the elaboration of a humoral factor that causes selective renal
phosphate wasting or from a more generalized cellular defect
that involves the gut and bone as well as kidney. The mouse
model for VDRR continues to provide useful information. In
1987, the gene for VDRR in humans was mapped to the distal
part of the short arm of the X chromosome. Characterization of
the aberrant gene and its product now becomes feasible.
Glorieux described how phosphate supplementation together
with administration of calcitriol has resulted in improved growth
rate, radiographic healing of rickets, and, in some subjects, correction of the mineralization defect at trabecular bone surfaces.
The discussion following Glorieux's presentation concerned
how hyperparathyroidism provoked by phosphate supplementation can be minimized in VDRR and what effects this medical
regimen has on the kidney of these patients.
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